[Antiviral and antiproliferative activity of human interferons and their induction of 2',5'-oligoadenylate synthetase]. 1986

T I Krispin, and A V Itkes, and I G Balandin, and M F Solov'eva, and V P Kuznetsov

Native preparations of alpha, beta and gamma-interferons as well as recombinant beta-interferon and purified leukocyte alpha-interferon and purified leukocyte alpha-interferon exert antiviral and antiproliferative activity in CaOv cells. Native interferon preparations were shown to be more antiproliferative than purified interferons per unit of antiviral activity (with EMC as well as with less susceptible VSV used as test viruses). It was shown that level of 2'5' oligoadenylatesynthetase activity induction in general correlates with antiproliferative and pronounced antiviral activity of interferons, besides that, the earlier (by 11 hours) induction of the enzyme activity by beta-interferon correlates with more rapid expression of antiproliferative effects by this interferon in comparison with that of alpha-interferon, the latter inducing the peak of enzyme activity by 24 hours.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015088 2',5'-Oligoadenylate Synthetase An enzyme that catalyzes the conversion of ATP into a series of (2'-5') linked oligoadenylates and pyrophosphate in the presence of double-stranded RNA. These oligonucleotides activate an endoribonuclease (RNase L) which cleaves single-stranded RNA. Interferons can act as inducers of these reactions. 2',5'-Oligoadenylate Polymerase,2-5A Synthetase,(2'-5')An Polymerase,2',5'-Oligo(A) Polymerase,2',5'-Oligo(A) Synthetase,2,5 Oligoadenylate Polymerase,2,5 Oligoadenylate Synthetase,ATP-(2'-5')oligo(A)adenylyltransferase,2',5' Oligoadenylate Polymerase,2',5' Oligoadenylate Synthetase,Oligoadenylate Polymerase, 2,5,Oligoadenylate Synthetase, 2,5,Polymerase, 2',5'-Oligoadenylate,Polymerase, 2,5 Oligoadenylate,Synthetase, 2',5'-Oligoadenylate,Synthetase, 2,5 Oligoadenylate

Related Publications

T I Krispin, and A V Itkes, and I G Balandin, and M F Solov'eva, and V P Kuznetsov
March 1992, Biology of reproduction,
T I Krispin, and A V Itkes, and I G Balandin, and M F Solov'eva, and V P Kuznetsov
January 1988, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
T I Krispin, and A V Itkes, and I G Balandin, and M F Solov'eva, and V P Kuznetsov
July 1985, Molecular and cellular biochemistry,
T I Krispin, and A V Itkes, and I G Balandin, and M F Solov'eva, and V P Kuznetsov
December 1988, The Journal of general virology,
T I Krispin, and A V Itkes, and I G Balandin, and M F Solov'eva, and V P Kuznetsov
July 2019, Wiley interdisciplinary reviews. RNA,
T I Krispin, and A V Itkes, and I G Balandin, and M F Solov'eva, and V P Kuznetsov
January 1997, Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica,
T I Krispin, and A V Itkes, and I G Balandin, and M F Solov'eva, and V P Kuznetsov
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
T I Krispin, and A V Itkes, and I G Balandin, and M F Solov'eva, and V P Kuznetsov
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
T I Krispin, and A V Itkes, and I G Balandin, and M F Solov'eva, and V P Kuznetsov
February 1993, AIDS research and human retroviruses,
T I Krispin, and A V Itkes, and I G Balandin, and M F Solov'eva, and V P Kuznetsov
March 1992, Leukemia,
Copied contents to your clipboard!